NASDAQ:BMGL Basel Medical Group (BMGL) Stock Price, News & Analysis $5.85 +0.06 (+1.04%) As of 12:52 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock About Basel Medical Group Stock (NASDAQ:BMGL) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Basel Medical Group alerts:Sign Up Key Stats Today's Range$5.41▼$5.8750-Day Range$5.26▼$8.3552-Week Range$4.60▼$27.36Volume2,535 shsAverage Volume28,955 shsMarket Capitalization$9.13 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore. Read More Basel Medical Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks7th Percentile Overall ScoreBMGL MarketRank™: Basel Medical Group scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingBasel Medical Group has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageBasel Medical Group has only been the subject of 1 research reports in the past 90 days.Read more about Basel Medical Group's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Book Value per Share RatioBasel Medical Group has a P/B Ratio of 2.34. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.09% of the float of Basel Medical Group has been sold short.Short Interest Ratio / Days to CoverBasel Medical Group has a short interest ratio ("days to cover") of 0.46, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Basel Medical Group has recently increased by 157.14%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBasel Medical Group does not currently pay a dividend.Dividend GrowthBasel Medical Group does not have a long track record of dividend growth. News and Social Media2.2 / 5News Sentiment0.44 News SentimentBasel Medical Group has a news sentiment score of 0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.92 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Basel Medical Group this week, compared to 1 article on an average week. Company OwnershipN/AInsider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Basel Medical Group insiders have not sold or bought any company stock.Percentage Held by InstitutionsBasel Medical Group has minimal institutional ownership at this time.Read more about Basel Medical Group's insider trading history. Receive BMGL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Basel Medical Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BMGL Stock News HeadlinesBasel Medical Group Ltd: BMGL Regains Compliance With Nasdaq Minimum Bid Price RequirementJuly 10, 2026 | finanznachrichten.deBasel Medical regains compliance with Nasdaq minimum bid price ruleJuly 10, 2026 | msn.comThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.July 27 at 1:00 AM | Chaikin Analytics (Ad)Basel Medical Group Regains Nasdaq Minimum Bid Price ComplianceJuly 10, 2026 | tipranks.comBasel Medical Group Ltd Regains Compliance with Nasdaq Minimum Bid Price RequirementJuly 10, 2026 | quiverquant.comQBMGL Regains Compliance With Nasdaq Minimum Bid Price RequirementJuly 10, 2026 | globenewswire.comBasel Medical Group Ltd (BMGL) Stock Price, Quote, News & HistoryJuly 3, 2026 | benzinga.comBasel Medical Group Swings to Interim Profit in December 2025 ResultsJune 26, 2026 | tipranks.comSee More Headlines BMGL Stock Analysis - Frequently Asked Questions How have BMGL shares performed this year? Basel Medical Group's stock was trading at $5.88 at the start of the year. Since then, BMGL stock has decreased by 3.1% and is now trading at $5.70. How were Basel Medical Group's earnings last quarter? Basel Medical Group Ltd (NASDAQ:BMGL) released its quarterly earnings results on Friday, June, 26th. The company reported $0.01 EPS for the quarter. The company had revenue of $3.21 million for the quarter. When did Basel Medical Group's stock split? Basel Medical Group shares reverse split on the morning of Monday, June 22nd 2026.A 1-12 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, June 21st 2026. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split. When did Basel Medical Group IPO? Basel Medical Group (BMGL) raised $10 million in an initial public offering on Tuesday, February 25th 2025. The company issued 2,205,000 shares at a price of $4.00-$5.00 per share. How do I buy shares of Basel Medical Group? Shares of BMGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings6/26/2026Today7/27/2026Fiscal Year End6/30/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical Services Sub-IndustryHealthcare Current SymbolNASDAQ:BMGL CIK2004489 WebN/A Phone(656) 291-9188FaxN/AEmployees36Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.93 Current Ratio1.88 Quick Ratio1.83 Sales & Book Value Annual Sales$8.90 million Price / Sales1.00 Cash FlowN/A Price / Cash FlowN/A Book Value$2.44 per share Price / Book2.34Miscellaneous Outstanding Shares1,560,000Free FloatN/AMarket Cap$8.89 million OptionableN/A Beta0.15 Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (NASDAQ:BMGL) was last updated on 7/27/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredElon's new "super startup"Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...Banyan Hill Publishing | SponsoredWhere to Put $100 Before Trump's New Tech Law Rolls OutThe Financial Times says a new tech law puts America 'on the verge of a financial revolution.' Yahoo Finance e...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Basel Medical Group Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Basel Medical Group With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BMGL Stock Alerts